A Remarkable Milestone: Celebrating the Inaugural UW IHDD Research Day
The University of Washington recently hosted the 1st annual UW Institute on Human Development and Disability (IHDD) Research Day, a significant milestone in the field of human development and [...]
FDA Approves First Gene Therapy for Duchenne Muscular Dystrophy
The Food and Drug Administration (FDA) has approved the first gene therapy for the treatment of Duchenne muscular dystrophy (DMD) in patients ages 4 through 5 years with a confirmed mutation in [...]
UW CHDD Promoted to UW IHDD with Sandra Juul as New Director
The University of Washington (UW) CHDD has recently been designated as the UW Institute on Human Development and Disability (IHDD), with Dr. Sandra Juul appointed as the new Director of the [...]